Responses

Download PDFPDF
Neonatal long lines
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Neonatal long lines and the risk of pericardial effusion

    Dear Editor

    Whilst the leading article by Menon [1] provides an excellent overview of the use and complications of different types of neonatal venous lines. We must point out that in our retrospective study,[2] we demonstrated that pericardial effusions (PCE) were extremely rare with an incidence of 1.8/1000 (0.18%) lines inserted not 1.8%. as stated by Dr Menon.

    We agree with Menon1 and the Associate E...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Catheter material

    Dear Editor

    It is interesting to hear of the French experience of long lines reported by Bedu et al.[1]

    It is difficult to come to conclusions about real differences in incidence of pericardial effusion (PCE) with different catheter types with just one adverse event in each group in the AFSSPS survey.[2] The results of this survey may hide other factors, including type of unit (amount of experien...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Neonatal long lines and pericardial effusions: a differance between silicone and polyurethane?
    • Antoine Bedu, MD
    • Other Contributors:
      • Philippe Brosset, Valerie Belin, and Sophie Ketterer

    Dear Editor

    We read with interest the articles of Menon and Beardsall et al.[1,2] especially as we recently experienced in a very low birth weight baby a pericardial effusion case related to a neonatal long line. This percutaneous long line was a polyurethane one and it was not surprising for us as the Agence Francaise de Sécurité Sanitaire des Produits de Santé (AFSSPS) (“French Agency for Health Products an...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Neonatal long lines- Are they safe?

    Dear Editor

    Neonatal long lines are essential part in the management of extremely low birth babies and very sick babies. Technically to insert a longline is not that difficult especially if attempted in the first few days but often we have to accept suboptimal positions. Definitely use of long lines have improved the outcome of babies weighing less than 1000grams and postoperative cases.

    More than safety we...

    Show More
    Conflict of Interest:
    None declared.